Novo Nordisk A/S (NVO)
43.24
+0.05
(+0.12%)
USD |
NYSE |
Sep 18, 16:00
43.26
+0.02
(+0.05%)
After-Hours: 20:00
Novo Nordisk Total Return Level : 77.38 for Sept. 18, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 18, 2026 | 77.38 |
| September 17, 2026 | 77.29 |
| September 16, 2026 | 74.64 |
| September 15, 2026 | 76.11 |
| September 14, 2026 | 77.76 |
| September 11, 2026 | 77.08 |
| September 10, 2026 | 78.76 |
| September 09, 2026 | 79.74 |
| September 08, 2026 | 80.82 |
| September 04, 2026 | 83.39 |
| September 03, 2026 | 85.02 |
| September 02, 2026 | 83.70 |
| September 01, 2026 | 80.74 |
| August 31, 2026 | 81.12 |
| August 28, 2026 | 81.62 |
| August 27, 2026 | 82.78 |
| August 26, 2026 | 84.45 |
| August 25, 2026 | 87.08 |
| August 24, 2026 | 83.97 |
| August 21, 2026 | 83.64 |
| August 20, 2026 | 82.57 |
| August 19, 2026 | 83.18 |
| August 18, 2026 | 81.80 |
| August 17, 2026 | 80.31 |
| August 14, 2026 | 81.08 |
| Date | Value |
|---|---|
| August 13, 2026 | 82.54 |
| August 12, 2026 | 81.96 |
| August 11, 2026 | 83.34 |
| August 10, 2026 | 84.33 |
| August 07, 2026 | 83.50 |
| August 06, 2026 | 81.22 |
| August 05, 2026 | 78.67 |
| August 04, 2026 | 78.23 |
| August 03, 2026 | 83.20 |
| July 31, 2026 | 83.18 |
| July 30, 2026 | 91.18 |
| July 29, 2026 | 91.13 |
| July 28, 2026 | 90.03 |
| July 27, 2026 | 87.76 |
| July 24, 2026 | 86.17 |
| July 23, 2026 | 85.12 |
| July 22, 2026 | 85.14 |
| July 21, 2026 | 87.24 |
| July 20, 2026 | 87.65 |
| July 17, 2026 | 88.90 |
| July 16, 2026 | 90.95 |
| July 15, 2026 | 89.33 |
| July 14, 2026 | 86.70 |
| July 13, 2026 | 87.07 |
| July 10, 2026 | 87.42 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AstraZeneca PLC | 419.21 |
| GSK Plc | 191.51 |
| Johnson & Johnson | 644.25 |
| Eli Lilly & Co. | 3046.28 |
| Merck & Co., Inc. | 454.18 |